From Wikipedia, the free encyclopedia
Chemical compound
Androisoxazole
Trade names Androxan, Neo-Ponden, Neo-Pondus Other names 17α-Methyl-5α-androstano[3,2-c]isoxazol-17β-ol
Routes of administration
By mouth
Drug class
Androgen ;
Anabolic steroid
2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-1,10a,12a-trimethyl-1H -cyclopenta[7,8]phenanthro[2,3-c ]isoxazol-1-ol
CAS Number
PubChem
CID
ChemSpider
UNII
CompTox Dashboard (
EPA )
Formula C 21 H 31 N O 2
Molar mass 329.484 g·mol−1 3D model (
JSmol )
O[C@@]5(C)CC[C@H]4[C@H]3[C@@H]([C@]2(Cc1c(noc1)C[C@@H]2CC3)C)CC[C@@]45C
InChI=1S/C21H31NO2/c1-19-11-13-12-24-22-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)23/h12,14-17,23H,4-11H2,1-3H3/t14-,15+,16-,17-,19-,20-,21-/m0/s1
Y Key:NSYTUNFHWYMMHU-IYRCEVNGSA-N
Y
(verify)
Androisoxazole (brand names Androxan , Neo-Ponden , Neo-Pondus ), also known as 17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol , is an
orally active
anabolic-androgenic steroid (AAS) and a
17α-alkylated
derivative of
dihydrotestosterone (DHT) that is marketed in
Spain and
Italy .
[1]
[2]
[3]
[4] It is closely related to
stanozolol , differing only in having an
isoxazole instead of
pyrazole
ring fused to the A ring,
[4] and is also related to
furazabol ,
prostanozol , and
danazol .
References
Androgens (incl.
AAS Tooltip anabolic–androgenic steroid )
Antiandrogens
AR Tooltip Androgen receptor
antagonists
Steroidogenesis inhibitors
Antigonadotropins
D2 receptor
antagonists (
prolactin releasers ) (e.g.,
domperidone ,
metoclopramide ,
risperidone ,
haloperidol ,
chlorpromazine ,
sulpiride )
Estrogens (e.g.,
bifluranol ,
diethylstilbestrol ,
estradiol ,
estradiol esters ,
ethinylestradiol ,
ethinylestradiol sulfonate ,
paroxypropione )
GnRH agonists (e.g.,
leuprorelin )
GnRH antagonists (e.g.,
cetrorelix )
Progestogens (incl.,
chlormadinone acetate ,
cyproterone acetate ,
hydroxyprogesterone caproate ,
gestonorone caproate ,
medroxyprogesterone acetate ,
megestrol acetate )
Others
AR Tooltip Androgen receptor
Agonists
SARMs Tooltip Selective androgen receptor modulator Antagonists
GPRC6A